Diabetes (Other)
10 drugs in this class, prescribed by 411,483 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$2.67B
Total Cost
22,787,802
Claims
10
Drugs
$117
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Januvia at $983/claim
- Most prescribed: Metformin Hcl with 14,222,346 claims
- This class represents 1.0% of total Medicare Part D spending
All Diabetes (Other) Drugs
| Drug | Cost | Claims |
|---|---|---|
| Sitagliptin Phosphate | $1.54B | 1,567,668 |
| Linagliptin | $403.8M | 519,439 |
| Sitagliptin Phos/Metformin Hcl | $302.2M | 329,315 |
| Metformin Hcl | $218.8M | 14,222,346 |
| Dapaglifloz Propaned/Metformin | $54.4M | 58,629 |
| Glipizide | $46.9M | 2,961,035 |
| Glimepiride | $25.3M | 1,885,737 |
| Pioglitazone Hcl | $24.8M | 1,182,614 |
| Linagliptin/Metformin Hcl | $24.3M | 33,018 |
| Empaglifloz/Linaglip/Metformin | $23.9M | 28,001 |